NanoString Technologies (NASDAQ:NSTG) is scheduled to be announcing its earnings results after the market closes on Tuesday, February 27th. Analysts expect the company to announce earnings of ($0.44) per share for the quarter.
NanoString Technologies (NASDAQ NSTG) opened at $7.00 on Tuesday. The firm has a market capitalization of $177.68, a P/E ratio of -3.38 and a beta of 0.78. The company has a current ratio of 3.35, a quick ratio of 2.89 and a debt-to-equity ratio of 1.08. NanoString Technologies has a 12-month low of $6.31 and a 12-month high of $20.70.
A number of equities analysts have weighed in on NSTG shares. Zacks Investment Research raised NanoString Technologies from a “hold” rating to a “buy” rating and set a $8.25 price target on the stock in a research report on Wednesday, January 3rd. ValuEngine downgraded NanoString Technologies from a “sell” rating to a “strong sell” rating in a research report on Friday, February 2nd. Finally, Robert W. Baird reissued a “buy” rating and set a $14.00 price target on shares of NanoString Technologies in a research report on Tuesday, October 24th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the company. NanoString Technologies presently has an average rating of “Hold” and a consensus price target of $15.06.
ILLEGAL ACTIVITY NOTICE: “NanoString Technologies (NSTG) Scheduled to Post Quarterly Earnings on Tuesday” was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US & international copyright legislation. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/02/20/nanostring-technologies-nstg-scheduled-to-post-quarterly-earnings-on-tuesday.html.
About NanoString Technologies
NanoString Technologies, Inc develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample.
Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.